Riskpilot← Back to searchSign inGet full accessDR TORRES AS
ASActiveOrg 924944854Bogstadveien 37, 0366 OsloGeneral medical practice activities · NACE 8621Est. 20201 employees
Revenue 2024
NOK 3,4M
+114% vs 2023
EBITDA margin
43.5%
+3363% vs 2023
Equity ratio
37.2%
Financial strength
Net profit 2024
NOK 1,2M
+2773% vs 2023
| Revenue | NOK 3,4M | +114% |
| EBITDA | NOK 1,5M | +3363% |
| Net profit | NOK 1,2M | +2773% |
| Total assets | NOK 3,2M | +118% |
| Equity | NOK 1,2M | +9392% |
| Employees | 1 | — |
Legal name
DR TORRES AS
Org number
924944854
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
20. april 2020
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Legevirksomhet og utføre aktiviteter og tjenester som er i nær relasjon med legeyrket. Det skal tilbys bistand og annen konsulentvirksomhet innenfor administrasjon. Videre skal selskapet også kunne bistå med finansiering til selskaper i samme konsern.
Address
Bogstadveien 37, 0366 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 6 | 1 239 | 772 | 1 585 | 3 397 |
| Staff expenses | −0 | −569 | −413 | −728 | −762 |
| EBITDA | 6 | 272 | −185 | −45 | 1 477 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −12 |
| EBIT | 6 | 272 | −185 | −45 | 1 465 |
| Net financials | 0 | −1 | −0 | 1 | 0 |
| Profit before tax | 6 | 271 | −185 | −45 | 1 465 |
| Tax | −0 | 60 | −0 | −0 | 272 |
| Net profit | 6 | 212 | −185 | −45 | 1 193 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 36 | 742 | 1 436 | 1 487 | 3 245 |
| Equity | 30 | 242 | 57 | 13 | 1 206 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 6 | 500 | 1 379 | 1 474 | 2 039 |
| Total debt | 6 | 500 | 1 379 | 1 474 | 2 039 |
EBITDA margin
43.5%
This company
15.8%
Market median
+175% vs market
20202024
Equity ratio
37.2%
This company
38.2%
Market median
+3% vs market
20202024
Return on equity
98.9%
This company
18.4%
Market median
+438% vs market
20202024
Net profit margin
35.1%
This company
8.1%
Market median
+333% vs market
20202024
Asset turnover
1.05×
This company
1.12×
Market median
+6% vs market
20202024
Debt / equity
1.69×
This company
0.62×
Market median
-173% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-21 – 2020-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MI Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Dr Torres Invest As | Company | 100.0% | 100.0% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Dr Torres Invest As
DR TORRES AS Board members of DR TORRES AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Maelyn Ignacio Torres | Chief Executive Officer | 0 companies |
| Marvin-Jay Ignacio Torres | Board of Directors | 0 companies |